HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sarah Lévesque Selected Research
Sarah Lévesque Research Topics
Disease
9
Neoplasms (Cancer)
01/2022 - 01/2018
1
Lung Neoplasms (Lung Cancer)
01/2022
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1
Obesity
11/2020
1
Breast Neoplasms (Breast Cancer)
01/2019
1
Melanoma (Melanoma, Malignant)
01/2018
Drug/Important Bio-Agent (IBA)
2
Immune Checkpoint Inhibitors
IBA
01/2019 - 01/2019
2
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2019 - 01/2019
1
Cisplatin (Platino)
FDA Link
Generic
01/2022
1
Poly (ADP-Ribose) Polymerase-1
IBA
01/2022
1
Inducible T-Cell Co-Stimulator Protein
IBA
01/2022
1
niraparib
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
10/2021
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2020
1
Programmed Cell Death 1 Receptor
IBA
01/2019
1
hydroxycitric acid
IBA
01/2019
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2019
1
Immune Checkpoint Proteins
IBA
01/2019
1
Antigens
IBA
01/2019
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2019
1
Carcinogens
IBA
01/2019
1
Spermidine
IBA
01/2019
1
B7-H1 Antigen
IBA
01/2019
1
LTX-401
IBA
01/2019
1
Vaccines
IBA
01/2019
1
Anthracyclines
IBA
01/2019
1
Calreticulin
IBA
01/2019
1
talimogene laherparepvec
IBA
01/2018
Therapy/Procedure
3
Therapeutics
01/2019 - 01/2019
2
Drug Therapy (Chemotherapy)
01/2019 - 01/2019
2
Immunotherapy
01/2019 - 01/2018
1
Injections
01/2019
1
Caloric Restriction
01/2019